New Enterprise Associates 15, L.P., 10% Owner at Inozyme Pharma, Inc. (INZY), bought 2,250,533 shares at $16.00 ($4.0M) on 2020-07-28, disclosed to the SEC on 2020-07-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,000,533 | $0 | 0.0% |
| 2 | $16.00 | 250,000 | $4.0M | 100.0% |
| Total | $1.78 avg | 2,250,533 | $4.0M | 100% |
| Filing → |
| AVEO | BUY | 2018-11-30 | $191K | — | Filing → |
| AVEO | BUY | 2018-11-21 | $337K | — | Filing → |
| AVEO | BUY | 2018-07-20 | $491K | — | Filing → |